In the past week, RXST stock has gone down by -12.46%, with a monthly decline of -45.57% and a quarterly plunge of -58.87%. The volatility ratio for the week is 13.03%, and the volatility levels for the last 30 days are 6.83% for RxSight Inc The simple moving average for the last 20 days is -36.97% for RXST stock, with a simple moving average of -65.91% for the last 200 days.
Is It Worth Investing in RxSight Inc (NASDAQ: RXST) Right Now?
RXST has 36-month beta value of 1.37. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for RXST is 38.38M, and currently, short sellers hold a 8.19% ratio of that float. The average trading volume of RXST on April 11, 2025 was 771.09K shares.
RXST) stock’s latest price update
The stock of RxSight Inc (NASDAQ: RXST) has decreased by -8.51 when compared to last closing price of 15.51. Despite this, the company has experienced a -12.46% fall in its stock price over the last five trading sessions. https://thefly.com reported 2025-04-07 that Wells Fargo lowered the firm’s price target on RxSight to $17 from $22 and keeps an Equal Weight rating on the shares following the conference call to discuss the preliminary Q1 2025 sales results and lowered FY25 guidance. The company called out weak LAL volume trends through Q1, especially March, competitive product launches, and recessionary concerns, Wells notes. 09 May
Analysts’ Opinion of RXST
Many brokerage firms have already submitted their reports for RXST stocks, with UBS repeating the rating for RXST by listing it as a “Neutral.” The predicted price for RXST in the upcoming period, according to UBS is $16 based on the research report published on April 09, 2025 of the current year 2025.
JP Morgan, on the other hand, stated in their research note that they expect to see RXST reach a price target of $17, previously predicting the price at $40. The rating they have provided for RXST stocks is “Underweight” according to the report published on April 04th, 2025.
BofA Securities gave a rating of “Underperform” to RXST, setting the target price at $22 in the report published on April 03rd of the current year.
RXST Trading at -47.11% from the 50-Day Moving Average
After a stumble in the market that brought RXST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.67% of loss for the given period.
Volatility was left at 6.83%, however, over the last 30 days, the volatility rate increased by 13.03%, as shares sank -43.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -55.07% lower at present.
During the last 5 trading sessions, RXST fell by -12.46%, which changed the moving average for the period of 200-days by -74.56% in comparison to the 20-day moving average, which settled at $22.51. In addition, RxSight Inc saw -58.73% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RXST starting from Fountain Tamara, who sale 7,000 shares at the price of $25.71 back on Mar 12 ’25. After this action, Fountain Tamara now owns 24,793 shares of RxSight Inc, valued at $180,002 using the latest closing price.
TAMARA R FOUNTAIN, the Director of RxSight Inc, proposed sale 7,000 shares at $25.71 during a trade that took place back on Mar 12 ’25, which means that TAMARA R FOUNTAIN is holding shares at $180,002 based on the most recent closing price.
Stock Fundamentals for RXST
Current profitability levels for the company are sitting at:
- -0.25 for the present operating margin
- 0.66 for the gross margin
The net margin for RxSight Inc stands at -0.18. The total capital return value is set at -0.13. Equity return is now at value -12.43, with -10.90 for asset returns.
Based on RxSight Inc (RXST), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -1.38. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -1675.32.
Currently, EBITDA for the company is -23.76 million with net debt to EBITDA at 0.19. When we switch over and look at the enterprise to sales, we see a ratio of 3.8. The receivables turnover for the company is 4.99for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.36.
Conclusion
To put it simply, RxSight Inc (RXST) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
